DOXIMITY INC-CLASS A (DOCS) Stock Fundamental Analysis
USA • New York Stock Exchange • NYSE:DOCS • US26622P1075
37.47 USD
-1.16 (-3%)
At close: Jan 30, 2026
37.47 USD
0 (0%)
After Hours: 1/30/2026, 8:04:00 PM
Overall DOCS gets a fundamental rating of 7 out of 10. We evaluated DOCS against 35 industry peers in the Health Care Technology industry. DOCS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. DOCS is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings could make DOCS a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
- In the past year DOCS was profitable.
- In the past year DOCS had a positive cash flow from operations.
- DOCS had positive earnings in each of the past 5 years.
- DOCS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- DOCS has a better Return On Assets (20.13%) than 100.00% of its industry peers.
- The Return On Equity of DOCS (23.10%) is better than 100.00% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 18.16%, DOCS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for DOCS is significantly above the industry average of 6.63%.
- The last Return On Invested Capital (18.16%) for DOCS is above the 3 year average (14.17%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.13% | ||
| ROE | 23.1% | ||
| ROIC | 18.16% |
ROA(3y)13.75%
ROA(5y)12.65%
ROE(3y)16.22%
ROE(5y)15.68%
ROIC(3y)14.17%
ROIC(5y)16.48%
1.3 Margins
- DOCS has a better Profit Margin (40.72%) than 100.00% of its industry peers.
- DOCS's Profit Margin has improved in the last couple of years.
- DOCS's Operating Margin of 39.72% is amongst the best of the industry. DOCS outperforms 100.00% of its industry peers.
- DOCS's Operating Margin has improved in the last couple of years.
- DOCS's Gross Margin of 90.20% is amongst the best of the industry. DOCS outperforms 97.14% of its industry peers.
- In the last couple of years the Gross Margin of DOCS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 39.72% | ||
| PM (TTM) | 40.72% | ||
| GM | 90.2% |
OM growth 3Y6.88%
OM growth 5Y16.16%
PM growth 3Y0.28%
PM growth 5Y33.35%
GM growth 3Y0.66%
GM growth 5Y0.68%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), DOCS is creating value.
- DOCS has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, DOCS has more shares outstanding
- There is no outstanding debt for DOCS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- DOCS has an Altman-Z score of 28.42. This indicates that DOCS is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of DOCS (28.42) is better than 100.00% of its industry peers.
- There is no outstanding debt for DOCS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 28.42 |
ROIC/WACC1.93
WACC9.4%
2.3 Liquidity
- A Current Ratio of 7.79 indicates that DOCS has no problem at all paying its short term obligations.
- DOCS has a Current ratio of 7.79. This is amongst the best in the industry. DOCS outperforms 91.43% of its industry peers.
- A Quick Ratio of 7.79 indicates that DOCS has no problem at all paying its short term obligations.
- DOCS's Quick ratio of 7.79 is amongst the best of the industry. DOCS outperforms 91.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.79 | ||
| Quick Ratio | 7.79 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 46.43% over the past year.
- Measured over the past years, DOCS shows a very strong growth in Earnings Per Share. The EPS has been growing by 79.21% on average per year.
- Looking at the last year, DOCS shows a very strong growth in Revenue. The Revenue has grown by 20.21%.
- DOCS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 37.42% yearly.
EPS 1Y (TTM)46.43%
EPS 3Y20.79%
EPS 5Y79.21%
EPS Q2Q%50%
Revenue 1Y (TTM)20.21%
Revenue growth 3Y18.42%
Revenue growth 5Y37.42%
Sales Q2Q%23.16%
3.2 Future
- DOCS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.75% yearly.
- Based on estimates for the next years, DOCS will show a quite strong growth in Revenue. The Revenue will grow by 11.49% on average per year.
EPS Next Y14.19%
EPS Next 2Y11.57%
EPS Next 3Y11.76%
EPS Next 5Y14.75%
Revenue Next Year14.06%
Revenue Next 2Y12.59%
Revenue Next 3Y12.01%
Revenue Next 5Y11.49%
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- DOCS is valuated rather expensively with a Price/Earnings ratio of 22.85.
- DOCS's Price/Earnings ratio is a bit cheaper when compared to the industry. DOCS is cheaper than 80.00% of the companies in the same industry.
- DOCS's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.30.
- A Price/Forward Earnings ratio of 21.35 indicates a rather expensive valuation of DOCS.
- Based on the Price/Forward Earnings ratio, DOCS is valued a bit cheaper than 74.29% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of DOCS to the average of the S&P500 Index (25.57), we can say DOCS is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.85 | ||
| Fwd PE | 21.35 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, DOCS is valued a bit cheaper than 62.86% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, DOCS is valued a bit cheaper than the industry average as 74.29% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.6 | ||
| EV/EBITDA | 21.14 |
4.3 Compensation for Growth
- DOCS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The excellent profitability rating of DOCS may justify a higher PE ratio.
PEG (NY)1.61
PEG (5Y)0.29
EPS Next 2Y11.57%
EPS Next 3Y11.76%
5. Dividend
5.1 Amount
- No dividends for DOCS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
DOXIMITY INC-CLASS A / DOCS FAQ
What is the fundamental rating for DOCS stock?
ChartMill assigns a fundamental rating of 7 / 10 to DOCS.
What is the valuation status for DOCS stock?
ChartMill assigns a valuation rating of 4 / 10 to DOXIMITY INC-CLASS A (DOCS). This can be considered as Fairly Valued.
How profitable is DOXIMITY INC-CLASS A (DOCS) stock?
DOXIMITY INC-CLASS A (DOCS) has a profitability rating of 9 / 10.
What are the PE and PB ratios of DOXIMITY INC-CLASS A (DOCS) stock?
The Price/Earnings (PE) ratio for DOXIMITY INC-CLASS A (DOCS) is 22.85 and the Price/Book (PB) ratio is 6.44.
What is the earnings growth outlook for DOXIMITY INC-CLASS A?
The Earnings per Share (EPS) of DOXIMITY INC-CLASS A (DOCS) is expected to grow by 14.19% in the next year.